AndrewBentallMDMBChB
Nephrology • Rochester, MNChronic Renal Failure & Dialysis, Glomerular Disease, Kidney & Pancreas Transplantation
Assistant Professor Nephrology and Transplant Medicine
Dr. Bentall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Andrew Bentall is a nephrologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from Birmingham, UK and has been in practice 13 years. He specializes in glomerular disease and kidney & pancreas transplantation.
Education & Training
Birmingham University Medical SchoolClass of 2004
Certifications & Licensure
WI State Medical License 2021 - 2025
MN State Medical License 2017 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 43 citationsLong‐term outcomes of eculizumab‐treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor‐specific antibodiesCarrie A. Schinstock, Andrew Bentall, Byron H. Smith, Lynn D. Cornell, Matthew J Everly
American Journal of Transplantation. 2019-06-01 - 40 citationsUse of Eculizumab for Active Antibody-mediated Rejection That Occurs Early Post-kidney Transplantation: A Consecutive Series of 15 Cases.Ek Khoon Tan, Andrew Bentall, Patrick G. Dean, Mohammed F Shaheen, Mark D. Stegall
Transplantation. 2019-11-01 - 20 citationsIdentification of Genetic Causes of Focal Segmental Glomerulosclerosis Increases With Proper Patient SelectionJing Miao, Filippo Vairo, Marie C. Hogan, Stephen B. Erickson, Mireille El Ters
Mayo Clinic Proceedings. 2021-09-01
Journal Articles
- Long‐Term Outcomes of Eculizumab‐Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor‐Specific AntibodiesMatthew Everly, Lynn D Cornell, Carrie A Schinstock, Andrew J Bentall, Mark D Stegall, American journal of transplantation
Press Mentions
Research News Roundup — January, February 2022March 2nd, 2022- Cancer, Infection Risk Higher in Transplant Patients Than RejectionFebruary 1st, 2022
- Study: COVID-19 Hospitalization Can Create Lasting Kidney DamageMarch 21st, 2021
- Join now to see all
Professional Memberships
- Member
- American Society of TransplantationMember
- British Transplant SocietyMember
- International Society of NephrologyMember
- The Transplantation SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
